Feedback / Questions
lirentelimab (AK002) - Allakos
http://www.ncbi.nlm.nih.gov/pubmed/35390403
Apr 8, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next